Holger Weis
Chairman of the Board & CEOMr. Holger Weis, CPA, serves as Chairman of the Board at Alaunos Therapeutics, Inc. and served as its Independent Chairman of the Board since September 22, 2023 and serves as its Chief Executive Officer since July 2, 2025. He has been Independent Director at Jupiter Neurosciences, Inc. (formerly Jupiter Orphan Therapeutics, Inc.) since September 8, 2021. He is the principal of Weis Advisors, Inc. He had been the Chief Financial Officer at EnSA Holdings, LLC from August 2010 to November 2011. He serves as Director at Alaunos Therapeutics, Inc. (formerly known as ZIOPHARM Oncology, Inc.) and served as its Independent Director since December 15, 2020. He has also served as the Chief Financial Officer and Director of PhenoTarget Biosciences, Inc., a biotech start-up company from April 2020 to March 2021. Prior to that, he served in a number of roles at DemeRx, Inc., a clinical stage pharmaceutical company developing nonaddictive treatments for drug addiction, including serving as Chief Operating Officer and Chief Financial Officer from December 2011 to July 2017 and also as President from September 2014 to July 2017 and as a Consultant from July 2017 to April 2018. He has long span of past work as an accomplished Financial Management Executive. Prior to joining EnSA, he served as Vice President and Chief Financial Officer, Secretary and Treasurer of Novavision, Inc. from January 2006 to August 2010, where he was responsible for finance, administration, clinical research and operations. He served as the Chief Financial Officer of GMP Companies Inc. (now LifeSync Holdings, Inc.) and its subsidiaries since July 2000 until 2005 and served as its Principal Accounting Officer and Treasurer. Since June 1986 until joining Gmp Companies Inc., he served as an Accountant in various positions at Ernst & Young LLP. He served as Senior Manager of Ernst & Young LLP from 1986 to 2000 in Atlanta, Georgia in the audit and assurance advisory group. He served clients ranging from young entrepreneurial companies to large, publicly traded multinationals, consulting on accounting, compensation and mergers and acquisition matters. While at Ernst & Young in Germany from 1991 to 1994, he consulted with American, British and French multinationals conducting business in Europe. He is a Board Member of the Broward County Public Library Foundation. He is a Member of the American Institute of Certified Public Accountants and Financial Executives International. He is a Certified Public Accountant licensed in Florida and Georgia. He has a Bachelor of Business Administration in Accounting from the University of Georgia in 1985.
Positions
- Company NameAlaunos Therapeutics, Inc.Stock CodeTCRTPositionChairman of the Board & CEO
